Pearl Health, a leading provider of physician enablement and risk management technology and services, today announced that the Pearl Health Application has earned certified status by HITRUST for ...
BetterWaytm blood testing by Babson Diagnostics today announced that it has entered into an agreement with Sam's Club, a division of Walmart Inc., to offer friendly, convenient, and affordable blood ...
ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (GSK), with Pfizer Inc. and Shionogi ...
Quebec is the first province to publicly cover costs of long-acting injectable HIV prevention medication Apretude. Experts ...
Zacks Investment Research on MSN6d
GILD Stock Down on Report of Cut in HIV Prevention SpendingShares of Gilead Sciences, Inc. GILD were down 2.47% after the Wall Street Journal reported that The Health and Human ...
Latonia Wilkins knows she needs to be on PrEP due to her non-monogamous lifestyle. But the 52-year-old Atlanta mother has ...
Like most prescribed medications, all three brands PrEP brands feature side effects. Here's how to prepare for them.
New real-world and implementation study data highlight the efficacy of ViiV’s long-acting injectables for HIV prevention and ...
Gilead has reported results for a once-yearly intramuscular injection that show blood concentrations of lenacapavir exceeded ...
The early results of trials for two injectable, investigational antiretroviral therapies, VH4524184 and VH4011499, have the ...
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced new data from two implementation studies showing zero cases of HIV ...
New data at CROI 2025 show zero cases of HIV acquisition reported with Apretude (cabotegravir long-acting (CAB LA) for PrEP) in varied clinical settings and populations in two implementation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback